Menu
Back to User profile » Dr Meletios-Athanasios Dimopoulos
Papers published by Dr Meletios-Athanasios Dimopoulos:
Referral for “Neoadjuvant Chemotherapy” for Muscle-Invasive Bladder Cancer to a Multidisciplinary Board: Patterns, Management and Outcomes
Dellis A, Zakopoulou R, Kougioumtzopoulou A, Tzannis K, Koutsoukos K, Fragkoulis C, Kostouros E, Papatsoris A, Varkarakis I, Stravodimos K, Boutati E, Pagoni S, Seferlis M, Chrisofos M, Kouloulias V, Ntoumas K, Deliveliotis C, Constantinides C, Dimopoulos MA, Bamias A
Cancer Management and Research 2021, 13:5941-5955
Published Date: 30 July 2021
Metastatic Hepatic Epithelioid Hemangioendothelioma Treated with Olaratumab: A Falling Star Rising?
Kyriazoglou A, Koutsoukos K, Zagouri F, Liontos M, Dimitriadis E, Tiniakos D, Dimopoulos MA
Therapeutics and Clinical Risk Management 2020, 16:141-146
Published Date: 27 February 2020
Evaluating ibrutinib in the treatment of symptomatic Waldenstrom’s macroglobulinemia
Papanota AM, Ntanasis-Stathopoulos I, Kastritis E, Dimopoulos MA, Gavriatopoulou M
Journal of Blood Medicine 2019, 10:291-300
Published Date: 27 August 2019
Evaluation of MET T1010I and MET rs40239 single-nucleotide polymorphisms in triple-negative breast cancer: a case–control study
Kalapanida D, Zagouri F, Gazouli M, Tsiakou A, Zografos E, Dimitrakakis C, Marinopoulos S, Giannos A, Sergentanis TN, Kastritis E, Terpos E, Dimopoulos MA
OncoTargets and Therapy 2019, 12:4195-4202
Published Date: 28 May 2019
Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function
Li Y, Wang X, O’Mara E, Dimopoulos MA, Sonneveld P, Weisel KC, Matous J, Siegel DS, Shah JJ, Kueenburg E, Sternas L, Cavanaugh C, Zaki M, Palmisano M, Zhou S
Clinical Pharmacology: Advances and Applications 2017, 9:133-145
Published Date: 8 November 2017
Untreated newly diagnosed essential hypertension is associated with nonalcoholic fatty liver disease in a population of a hypertensive center
Michopoulos S, Chouzouri VI, Manios ED, Grapsa E, Antoniou Z, Papadimitriou CA, Zakopoulos N, Dimopoulos AM
Clinical and Experimental Gastroenterology 2016, 9:1-9
Published Date: 13 January 2016
Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review
Zagouri F, Sergentanis TN, Chrysikos D, Dimopoulos MA, Bamias A
OncoTargets and Therapy 2015, 8:2187-2198
Published Date: 20 August 2015
Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor?
Giannos A, Filipits M, Zagouri F, Brandstetter A, Tsigginou A, Sotiropoulou M, Papaspyrou I, Sergentanis TN, Psaltopoulou T, Rodolakis A, Antsaklis A, Dimopoulos MA, Dimitrakakis C
OncoTargets and Therapy 2015, 8:1843-1847
Published Date: 23 July 2015
Profile of trebananib (AMG386) and its potential in the treatment of ovarian cancer
Liontos M, Lykka M, Dimopoulos MA, Bamias A
OncoTargets and Therapy 2014, 7:1837-1845
Published Date: 4 October 2014
Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma
Terpos E, Kanellias N, Christoulas D, Kastritis E, Dimopoulos MA
OncoTargets and Therapy 2013, 6:531-538
Published Date: 10 May 2013